Drug Trial Radar · NCT06737666
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
Last checked: Nov 20, 2026Latest source record: Dec 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
May 29, 2023
Primary completion
Oct 8, 2025
Study completion Dec 2025
Sponsor
- Lead sponsor
- Xiyuan Hospital of China Academy of Chinese Medical SciencesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Dec 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.
Conditions
- Diarrhea-predominant Irritable Bowel Syndrome
Interventions
Tong-Xie-Yao-FangDrug
Tong-Xie-Yao-Fang granules were taken 2 bags at a time, 2 times per day at 1h after meal for 4 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Fecal metagenomic detection of bacteria associated with Trp metabolismTime frame: 16weeks
- Serum detection by ElisaTime frame: 16weeks
- Serum Trp metabolism was measured by metabolomicsTime frame: 16weeks
- Th17/Treg ratio in peripheral blood was measured by flow cytometryTime frame: 16weeks
- Colon tissue was detected by immunofluorescence and histochemistry analysisTime frame: 16weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Beijing, Beijing Municipality, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.